Feasibility of concomitant MitraClip and left atrial appendage occlusion

被引:0
作者
Kuwata, Shingo [1 ]
Taramasso, Maurizio [1 ]
Zuber, Michel [1 ]
Suetsch, Gabor [1 ,2 ]
Attinger-Toller, Adrian [1 ]
Wicki, David [1 ]
Maisano, Francesco [1 ]
Nietlispach, Fabian [1 ]
机构
[1] Univ Heart Ctr, Ramistr 100, CH-8091 Zurich, Switzerland
[2] HerzZentrum Hirslanden, Zurich, Switzerland
关键词
atrial fibrillation; left atrial appendage occlusion; mitral valve repair; CHRONIC KIDNEY-DISEASE; AORTIC-VALVE-REPLACEMENT; TO-EDGE REPAIR; STROKE PREVENTION; SINGLE PROCEDURE; FIBRILLATION; IMPACT; CLOSURE; WARFARIN; OUTCOMES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: The aim of our study is to report our single-centre experience with concomitant MitraClip (MC) and left atrial appendage occlusion (LAAO) and further to assess the feasibility, safety and short-tenn outcome of such an approach. Methods and results: Twenty-five consecutive patients underwent MC with concomitant LAAO at our hospital (combined group). As a control group, 25 consecutive patients with atrial fibrillation (AF) undergoing standalone MC were selected. Baseline parameters were equal between the two groups. Patients in the combined group had longer procedural time (90.0 min vs. 66.0 min, p=0.02) and radiation time (32.0 min vs. 18.0 min, p=0.01). There were no procedural deaths. At 30 days, one patient died due to cerebral haemorrhage (combined vs. control: 4% vs. 0%, p=0.32) and two had acute kidney injury (combined vs. control: 4% vs. 4%, p=1.00). In multivariate analysis, the association of LAAO with device or procedural success was not significant. Conclusions: LAAO along with MC in a single stage procedure is feasible. These preliminary results have to be validated in a large randomised study, in order to assess the efficacy of combined LAAO that can be expected to become evident only after longer follow-up.
引用
收藏
页码:1940 / 1945
页数:6
相关论文
共 27 条
[1]   MitraClip therapy and surgical edge-to-edge repair in patients with severe left ventricular dysfunction and secondary mitral regurgitation: is the solution here? [J].
Antunes, Manuel J. .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 49 (01) :263-264
[2]   "One-Stop Shop" Safety of Combining Transcatheter Aortic Valve Replacement and Left Atrial Appendage Occlusion [J].
Attinger-Toller, Adrian ;
Maisano, Francesco ;
Senn, Oliver ;
Taramasso, Maurizio ;
Shakir, Samera ;
Possner, Mathias ;
Gloekler, Steffen ;
Windecker, Stephan ;
Stortecky, Stefan ;
Luscher, Thomas F. ;
Meier, Bernhard ;
Nietlispach, Fabian .
JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (14) :1487-1495
[3]   Incidence, Predictors, and Prognostic Impact of Late Bleeding Complications After Transcatheter Aortic Valve Replacement [J].
Genereux, Philippe ;
Cohen, David J. ;
Mack, Michael ;
Rodes-Cabau, Josep ;
Yadav, Mayank ;
Xu, Ke ;
Parvataneni, Rupa ;
Hahn, Rebecca ;
Kodali, Susheel K. ;
Webb, John G. ;
Leon, Martin B. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (24) :2605-2615
[4]   Effects of Atrial Fibrillation on Treatment of Mitral Regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) Randomized Trial [J].
Herrmann, Howard C. ;
Gertz, Zachary M. ;
Silvestry, Frank E. ;
Wiegers, Susan E. ;
Woo, Y. Joseph ;
Hermiller, James ;
Segar, Douglas ;
Heimansohn, David ;
Gray, William ;
Homma, Shunichi ;
Argenziano, Michael ;
Wang, Andrew ;
Jollis, James ;
Lampert, Mark B. ;
Alexander, John ;
Mauri, Laura ;
Foster, Elyse ;
Glower, Donald ;
Feldman, Ted .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (14) :1312-1319
[5]   Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial [J].
Holmes, David R. ;
Reddy, Vivek Y. ;
Turi, Zoltan G. ;
Doshi, Shephal K. ;
Sievert, Horst ;
Buchbinder, Maurice ;
Mullin, Christopher M. ;
Sick, Peter .
LANCET, 2009, 374 (9689) :534-542
[6]   Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation A Patient-Level Meta-Analysis [J].
Holmes, David R., Jr. ;
Doshi, Shephal K. ;
Kar, Saibal ;
Price, Matthew J. ;
Sanchez, Jose M. ;
Sievert, Horst ;
Valderrabano, Miguel ;
Reddy, Vivek Y. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (24) :2614-2623
[7]   Impact of left ventricular systolic dysfunction on the outcomes of percutaneous edge-to-edge mitral valve repair using MitraClip [J].
Kaneko, Hidehiro ;
Neuss, Michael ;
Schau, Thomas ;
Weissenborn, Jens ;
Butter, Christian .
HEART AND VESSELS, 2016, 31 (12) :1988-1996
[8]   Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation [J].
Kefer, Joelle ;
Tzikas, Apostolos ;
Freixa, Xavier ;
Shakir, Samera ;
Gafoor, Sameer ;
Nielsen-Kudsk, Jens Erik ;
Berti, Sergio ;
Santoro, Gennaro ;
Aminian, Adel ;
Landmesser, Ulf ;
Nietlispach, Fabian ;
Ibrahim, Reda ;
Danna, Paolo Luciano ;
Benit, Edouard ;
Budts, Werner ;
Stammen, Francis ;
De Potter, Tom ;
Tichelbaecker, Tobias ;
Gloekler, Steffen ;
Kanagaratnam, Prapa ;
Costa, Marco ;
Cruz-Gonzalez, Ignacio ;
Sievert, Horst ;
Schillinger, Wolfgang ;
Park, Jai-Wun ;
Meier, Bernhard ;
Omran, Heyder .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 207 :335-340
[9]   Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention [J].
Kitai, Yuichiro ;
Ozasa, Neiko ;
Morimoto, Takeshi ;
Bao, Bingyuan ;
Furukawa, Yutaka ;
Nakagawa, Yoshihisa ;
Kadota, Kazushige ;
Yanagita, Motoko ;
Shizuta, Satoshi ;
Kimura, Takeshi .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (06) :5221-5228
[10]   Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation [J].
Lip, Gregory Y. H. ;
Nieuwlaat, Robby ;
Pisters, Ron ;
Lane, Deirdre A. ;
Crijns, Harry J. G. M. .
CHEST, 2010, 137 (02) :263-272